Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Xingyi Kuang, Jianxiang Chi & Li Wang. (2016) Deregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromes. Hematology 21:10, pages 593-602.
Read now
Read now
Kui Wang, Canhua Huang & Edouard Collins Nice. (2014) Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers. Expert Review of Proteomics 11:2, pages 179-205.
Read now
Read now
Mingjie Tang, Lijun Lin, Haikang Cai, Jie Tang & Zubin Zhou. (2013) MicroRNA-145 downregulation associates with advanced tumor progression and poor prognosis in patients suffering osteosarcoma. OncoTargets and Therapy 6, pages 833-838.
Read now
Read now
Articles from other publishers (20)
Ryutaro Yoshikawa, Jun Inoue, Ryota Iwasaki, Mitsuhiko Terauchi, Yuji Fujii, Maya Ohta, Tomomi Hasegawa, Rui Mizuno, Takashi Mori & Johji Inazawa. (2023) Therapeutic applications of local injection of hsa-miR-634 into canine spontaneous malignant melanoma tumors. Cancer Gene Therapy 30:11, pages 1524-1529.
Crossref
Crossref
Joanna Szczepanek, Monika Skorupa, Joanna Jarkiewicz-Tretyn, Cezary Cybulski & Andrzej Tretyn. (2023) Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA. International Journal of Molecular Sciences 24:8, pages 7235.
Crossref
Crossref
Yegane Mirahmadi, Reza Nabavi, Fourough Taheri, Mohammad Mahdi Samadian, Zari Naderi Ghale-Noie, Mahsa Farjami, Abbas Samadi-khouzani, Meysam Yousefi, Sara Azhdari, Arash Salmaninejad & Amirhossein Sahebkar. (2021) MicroRNAs as Biomarkers for Early Diagnosis, Prognosis, and Therapeutic Targeting of Ovarian Cancer. Journal of Oncology 2021, pages 1-25.
Crossref
Crossref
Ryutaro Yoshikawa, Kazuki Heishima, Yoshihito Ueno, Miwa Kawade, Yusuke Maeda, Kyoko Yoshida, Mami Murakami, Hiroki Sakai, Yukihiro Akao & Takashi Mori. (2020) Development of synthetic microRNA‐214 showing enhanced cytotoxicity and RNase resistance for treatment of canine hemangiosarcoma. Veterinary and Comparative Oncology 18:4, pages 570-579.
Crossref
Crossref
Vivek KumarSameer GuptaKachnar VarmaManisha Sachan. (2020) microRNA as Biomarker in Ovarian Cancer Management: Advantages and Challenges. DNA and Cell Biology 39:12, pages 2103-2124.
Crossref
Crossref
Chu Pan, Jiawei Luo & Jiao Zhang. (2020) Computational Identification of RNA-Seq Based miRNA-Mediated Prognostic Modules in Cancer. IEEE Journal of Biomedical and Health Informatics 24:2, pages 626-633.
Crossref
Crossref
Pei Liu, Jiawei Luo & Xiangtao Chen. (2020) miRCom: Tensor completion integrating multi-view information to deduce the potential disease-related miRNA-miRNA pairs. IEEE/ACM Transactions on Computational Biology and Bioinformatics, pages 1-1.
Crossref
Crossref
Fei Han, Ming-qian Zhang, Wen-bin Liu, Lei Sun, Xiang-lin Hao, Li Yin, Xiao Jiang, Jia Cao & Jin-yi Liu. (2018) SOX30 specially prevents Wnt-signaling to suppress metastasis and improve prognosis of lung adenocarcinoma patients. RESPIRATORY RESEARCH 19:1.
Crossref
Crossref
Julia Kovacova, Alexandr Poprach, Tomas Buchler, William C. Cho & Ondrej Slaby. (2018) MicroRNAs as predictive biomarkers of response to tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma. Clinical Chemistry and Laboratory Medicine (CCLM) 56:9, pages 1426-1431.
Crossref
Crossref
Xun Cai, Chuan Liu, Tie‐Ning Zhang, Yi‐Wen Zhu, Xiao Dong & Peng Xue. (2018) Down‐regulation of FN1 inhibits colorectal carcinogenesis by suppressing proliferation, migration, and invasion. Journal of Cellular Biochemistry 119:6, pages 4717-4728.
Crossref
Crossref
William C.S. Cho. 2018. IASLC Thoracic Oncology. IASLC Thoracic Oncology
129
136.e2
.
Ahmad Mahdian-shakib, Ruhollah Dorostkar, Mahdi Tat, Mohammad Sadegh Hashemzadeh & Navid Saidi. (2016) Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer. Biomedicine & Pharmacotherapy 84, pages 592-600.
Crossref
Crossref
Fei Han, Wenbin Liu, Hualiang Xiao, Yan Dong, Lei Sun, Chengyi Mao, Li Yin, Xiao Jiang, Lin Ao, Zhihong Cui, Jia Cao & Jinyi Liu. (2015) High expression of SOX30 is associated with favorable survival in human lung adenocarcinoma. Scientific Reports 5:1.
Crossref
Crossref
Jonathan Rice, Henry Roberts, James Burton, Jianmin Pan, Vanessa States, Shesh N. Rai & Susan Galandiuk. (2015) Assay Reproducibility in Clinical Studies of Plasma miRNA. PLOS ONE 10:4, pages e0121948.
Crossref
Crossref
Attila A. Seyhan. (2015) microRNAs with different functions and roles in disease development and as potential biomarkers of diabetes: progress and challenges. Molecular BioSystems 11:5, pages 1217-1234.
Crossref
Crossref
Junjiang Deng, Yan Dong, Chong Li, Wenwei Zuo, Gang Meng, Chengping Xu & Jianjun Li. (2014) Decreased Expression of C10orf10 and Its Prognostic Significance in Human Breast Cancer. PLoS ONE 9:6, pages e99730.
Crossref
Crossref
Shaohua Wang, Hanjun Li, Jingjie Wang & Dan Wang. (2013) RETRACTED ARTICLE: Expression of microRNA-497 and its prognostic significance in human breast cancer. Diagnostic Pathology 8:1.
Crossref
Crossref
Shunsuke Noguchi, Junya Iwasaki, Minami Kumazaki, Takashi Mori, Kohji Maruo, Hiroki Sakai, Nami Yamada, Kazuyuki Shimada, Tomoki Naoe, Yukio Kitade & Yukihiro Akao. (2013) Chemically Modified Synthetic microRNA-205 Inhibits the Growth of Melanoma Cells In Vitro and In Vivo. Molecular Therapy 21:6, pages 1204-1211.
Crossref
Crossref
Hellen Kuasne, Fabio Marchi, Silvia Rogatto & Ilce de Syllos Cólus. (2013) Epigenetic Mechanisms in Penile Carcinoma. International Journal of Molecular Sciences 14:6, pages 10791-10808.
Crossref
Crossref
Ying Yin, Jun Li, Shujie Chen, Tianhua Zhou & Jianmin Si. (2012) MicroRNAs as Diagnostic Biomarkers in Gastric Cancer. International Journal of Molecular Sciences 13:12, pages 12544-12555.
Crossref
Crossref